Home › Trial NCT07856225
Clinical and Therapeutic Outcomes by Molecular Subtype in Breast Cancer
- Trial IDNCT07856225
- StatusRecruiting
- PhaseN/A
- Study typeObservational
- SponsorFundación Santa Fe de Bogota
- Enrollment370
- Start date2025-12-01
- ConditionsBreast Neoplasms · Triple Negative Breast Neoplasms · HER2-Positive Breast Cancer · Hormone Receptor-Positive Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.